Alba Therapeutics Corporation Company Profile

06:31 EDT 21st September 2017 | BioPortfolio

Alba Therapeutics Corporation is a Delaware Biopharmaceutical Company focused and the development, production and marketing of pharmaceuticals for the treatment of inflammatory and immune mediated diseases. Alba’s technology provides the ability to transiently, physiologically and reversibly open or close the tight junctions of internal barriers such as the intestinal mucosa and pulmonary epithelia. By altering paracellular permeability across these cell barriers, Alba seeks to develop therapeutic applications ranging from drug / vaccine delivery to therapies for diseases associated with tight junction dysfunction and autoimmunity.
As an emerging private entity Alba maximizes value creation by leveraging its human capital, partnerships and technology. The Company’s initial strategies are focused n moving its first drug candidates into human trials as quickly as possible, to provide therapeutic solutions that significantly improve patients’ lives. Equity and non-equity capital, such as SBIR and ATP grants, is being used to expand Alba’s powerful IP position while building the Company’s infrastructure and core competencies.
Mission Statement
Alba possesses revolutionary life science technology platforms and is dedicated to using these to identify the scientific and medical breakthrough required to discover, develop and market better medicines. This will enable patients to live longer, healthier, and more active lives.
Company Values
Our Culture is based on integrity, excellence and respect for people. We continue to excel by building an organization of the most talented people, in which the individuals and the work processes are aligned to achieve the Company’s business objectives.
We excel at discovering, developing and delivering superior therapeutics for our customers. We create value by modifying the course of disease and facilitating innovative therapies. The core of our innovative solutions rests upon our people, our science and our molecules. Our Products will address unmet clinical needs and significantly improve upon existing treatments.


Suite 400800 West Baltimore Street
United States of America


Phone: 410-319-0780
Fax: 410-319-0799

News Articles [1605 Associated News Articles listed on BioPortfolio]

Albino orangutan named 'Alba' after global appeal

A conservation group said Monday it has chosen the name Alba for a rare albino orangutan rescued from captivity in Indonesia after receiving a flood of suggestions from the public.

Global and Chinese Morus Alba Industry, 2017 Market Research Report [Report Updated: 01011970] Prices from USD $3000

The 'Global and Chinese Morus Alba Industry, 20122022 Market Research Report' is a professional and indepth study on the current state of the global Morus Alba industry with a focus on the Chinese mar...

Knight Therapeutics Inc. announces voting results from the Annual Meeting

MONTREAL, QUEBEC -- (Marketwired) -- 05/10/17 -- Knight Therapeutics Inc. (TSX: GUD) ("Knight" or the "Corporation") announced today the voting results from the Annual Meeting of the Shareholders he...


Girard Gibbs LLPEileen Epstein, 510-350-9728EJE@CLASSLAWGROUP.COM

Advanced Proteome Therapeutics Corporation Completes Rights Offering for Gross Proceeds of Approximately $430,000

VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 07/11/17 -- Advanced Proteome Therapeutics Corporation ("APC" or the "Company") (TSX VENTURE: APC)(FRANKFURT: 0E8) is pleased to report that it has co...

Concurrent with BMS acquisition, IFM Therapeutics spins off IFM Therapeutics LLC

Innate immunity-focused IFM Therapeutics is spinning off its non-oncology assets into the new company IFM Therapeutics LLC.

Intrinsic4D Inc. Announces Public Sale of Substantially all of the Assets of its Operating Subsidiary and Transfer to NEX

TORONTO, ONTARIO -- (Marketwired) -- 05/11/17 -- Intrinsic4D Inc. (the "Corporation") (TSX VENTURE: IFD) provides stakeholders with an update in relation to its financial status and solvency. Publi...

ProQR spins out Amylon Therapeutics for CNS therapeutics

ProQR Therapeutics has spun out Amylon Therapeutics, a privately-held company focused on the development of therapies for central nervous system (CNS) disorders, with seed funding from a group of inst...

PubMed Articles [590 Associated PubMed Articles listed on BioPortfolio]

Combination of a 2940 nm Er:YAG laser with recombinant bovine basic fibroblast growth factor (rb-bFGF) and light-emitting diode-red light (LED-RL) for the treatment of striae alba: A pilot study.

Striae distensae (SD) are a common dermatologic problem that plagues many people. Although there are many therapeutic modalities have been used to treat SD, effective method has been disappointing for...

Analyze moisture transformation and transport rules during processing of Paeoniae Radix Alba by using low-field NMR.

Moisture status and content during the processing of Paeoniae Radix Alba were studied by nuclear magnetic resonance (NMR) and nuclear magnetic resonance imaging (MRI) to investigate the changes of tra...

Inhibitory effect of an aqueous extract of Radix Paeoniae Alba on calcium oxalate nephrolithiasis in a rat model.

To examine the effect of an aqueous extract of Radix Paeoniae Alba (RPA) on the formation of calcium oxalate (CaOx) stones and the potential mechanism underlying the effect.

Isoprenylated phenolic compounds with PTP1B inhibition from Morus alba.

Two new Diels-Alder adducts, albasins A and B (1 and 2), one new isoprenylated 2-arylbenzofuran, albasin C (3), one new isoprenylated flavone, albasin D (4), together with sixteen known phenolic compo...

A Botanical Composition from Morus alba, Ilex paraguariensis, and Rosmarinus officinalis for Body Weight Management.

Obesity is the largest and fastest growing public health catastrophe in the world affecting both adults and children with a prevalence impacting more than one-third of United States (US) adult populat...

Clinical Trials [128 Associated Clinical Trials listed on BioPortfolio]

Prevalence of Psoriasis Alba in Psoriatic Patients

Interdigital psoriasis (psoriasis alba) is atypical and rare form of psoriasis that is often missed as it is commonly mistaken for either dermatoses or fungal infection.In this study we ob...

A Study to Evaluate the Efficacy of ELAPR in Women With Striae Distensae Alba

The study is designed to evaluate the efficacy of two formulations of a cross-linked tropoelastin matrix given the product codes ELAPR002f and ELAPR002g (collectively referred to as ELAPR ...

Association of Passiflora Incarnata L; Crataegus Oxyacantha L and Salix Alba L. on Mild and Moderate Anxiety

Phase III, multicentric, double blind, randomized study, controlled by Valeriana officinalis for evaluating the efficacy of association of Passiflora incarnata L; Crataegus Oxyacantha L an...

Optimizing Surgical Conditions During Laparoscopic Umbilical, Incisional -and Linea Alba Herniotomy With Deep Neuromuscular Blockade

The purpose of this study is to investigate surgical work space and surgical conditions in patients scheduled for laparoscopic umbilical, -linea alba and incisional herniotomy. The patient...

Impact of Ibis on Patients With Advanced COPD

The purpose of this research is to determine if Ibis™, a digital therapeutics solution developed by Senscio Systems, reduces the emergency room visits and hospitalizations of patients wi...

Companies [1319 Associated Companies listed on BioPortfolio]

Coach Alba

Founded in 2010, Coach Alba is a behavioral change company that builds innovative Web and mobile technologies to help people achieve life-changing goals. Headquartered in Provo, U...

Alba Lux Biomed S.L.

Alba Lux is a specialist translation, localization and cultural adaptation firm with a cumulative experience of many years in the translation and adaptation of biomedical literature. Alba Lux provides...

Alba Therapeutics Corporation

Alba Therapeutics Corporation is a Delaware Biopharmaceutical Company focused and the development, production and marketing of pharmaceuticals for the treatment of inflammatory and immune mediated dis...

Wellstat Therapeutics Corporation

Wellstat Therapeutics™ Corporation is a privately-held biopharmaceutical company located in Gaithersburg, Maryland. Dedicated to the discovery, development and commercialization of innovative therap...

Toshiba Corporation

Toshiba Medical Systems Corporation is a leading worldwide provider of medical diagnostic imaging systems and comprehensive medical solutions, such as CT, X-ray and vascular, ultr...

More Information about "Alba Therapeutics Corporation" on BioPortfolio

We have published hundreds of Alba Therapeutics Corporation news stories on BioPortfolio along with dozens of Alba Therapeutics Corporation Clinical Trials and PubMed Articles about Alba Therapeutics Corporation for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Alba Therapeutics Corporation Companies in our database. You can also find out about relevant Alba Therapeutics Corporation Drugs and Medications on this site too.

Quick Search

Relevant Topics

Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...

Pulmonary relating to or associated with the lungs eg Asthma, chronic bronchitis, emphysema, COPD, Cystic Fibrosis, Influenza,  Lung Cancer, Pneumonia, Pulmonary Arterial Hypertension, Sleep Disorders etc Follow and track Lung Cancer News ...

Corporate Database Quicklinks

Searches Linking to this Company Record